CCR2 and COVID-19: While increased CD38 expression across monocyte subsets was a general feature unrelated to disease severity, higher levels of CCR2 on iMonos, as well as lower levels of HLA-DR and CD86 with increased expression of CD163 in all monocyte subsets, were found in severe COVID-19 (Fig. 4E).